Engineering Approaches in Plant Molecular Farming for Global Health

Since the demonstration of the first plant-produced proteins of medical interest, there has been significant growth and interest in the field of plant molecular farming, with plants now being considered a viable production platform for vaccines. Despite this interest and development by a few biophar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Advaita Acarya Singh, Priyen Pillay, Tsepo Lebiletsa Tsekoa
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/34db2a8db141455c95644fe640a01266
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:34db2a8db141455c95644fe640a01266
record_format dspace
spelling oai:doaj.org-article:34db2a8db141455c95644fe640a012662021-11-25T19:10:48ZEngineering Approaches in Plant Molecular Farming for Global Health10.3390/vaccines91112702076-393Xhttps://doaj.org/article/34db2a8db141455c95644fe640a012662021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1270https://doaj.org/toc/2076-393XSince the demonstration of the first plant-produced proteins of medical interest, there has been significant growth and interest in the field of plant molecular farming, with plants now being considered a viable production platform for vaccines. Despite this interest and development by a few biopharmaceutical companies, plant molecular farming is yet to be embraced by ‘big pharma’. The plant system offers a faster alternative, which is a potentially more cost-effective and scalable platform for the mass production of highly complex protein vaccines, owing to the high degree of similarity between the plant and mammalian secretory pathway. Here, we identify and address bottlenecks in the use of plants for vaccine manufacturing and discuss engineering approaches that demonstrate both the utility and versatility of the plant production system as a viable biomanufacturing platform for global health. Strategies for improving the yields and quality of plant-produced vaccines, as well as the incorporation of authentic posttranslational modifications that are essential to the functionality of these highly complex protein vaccines, will also be discussed. Case-by-case examples are considered for improving the production of functional protein-based vaccines. The combination of all these strategies provides a basis for the use of cutting-edge genome editing technology to create a general plant chassis with reduced host cell proteins, which is optimised for high-level protein production of vaccines with the correct posttranslational modifications.Advaita Acarya SinghPriyen PillayTsepo Lebiletsa TsekoaMDPI AGarticleplant-made pharmaceuticalmolecular farmingvaccineglycoengineeringtyrosine sulfationproteases inactivationMedicineRENVaccines, Vol 9, Iss 1270, p 1270 (2021)
institution DOAJ
collection DOAJ
language EN
topic plant-made pharmaceutical
molecular farming
vaccine
glycoengineering
tyrosine sulfation
proteases inactivation
Medicine
R
spellingShingle plant-made pharmaceutical
molecular farming
vaccine
glycoengineering
tyrosine sulfation
proteases inactivation
Medicine
R
Advaita Acarya Singh
Priyen Pillay
Tsepo Lebiletsa Tsekoa
Engineering Approaches in Plant Molecular Farming for Global Health
description Since the demonstration of the first plant-produced proteins of medical interest, there has been significant growth and interest in the field of plant molecular farming, with plants now being considered a viable production platform for vaccines. Despite this interest and development by a few biopharmaceutical companies, plant molecular farming is yet to be embraced by ‘big pharma’. The plant system offers a faster alternative, which is a potentially more cost-effective and scalable platform for the mass production of highly complex protein vaccines, owing to the high degree of similarity between the plant and mammalian secretory pathway. Here, we identify and address bottlenecks in the use of plants for vaccine manufacturing and discuss engineering approaches that demonstrate both the utility and versatility of the plant production system as a viable biomanufacturing platform for global health. Strategies for improving the yields and quality of plant-produced vaccines, as well as the incorporation of authentic posttranslational modifications that are essential to the functionality of these highly complex protein vaccines, will also be discussed. Case-by-case examples are considered for improving the production of functional protein-based vaccines. The combination of all these strategies provides a basis for the use of cutting-edge genome editing technology to create a general plant chassis with reduced host cell proteins, which is optimised for high-level protein production of vaccines with the correct posttranslational modifications.
format article
author Advaita Acarya Singh
Priyen Pillay
Tsepo Lebiletsa Tsekoa
author_facet Advaita Acarya Singh
Priyen Pillay
Tsepo Lebiletsa Tsekoa
author_sort Advaita Acarya Singh
title Engineering Approaches in Plant Molecular Farming for Global Health
title_short Engineering Approaches in Plant Molecular Farming for Global Health
title_full Engineering Approaches in Plant Molecular Farming for Global Health
title_fullStr Engineering Approaches in Plant Molecular Farming for Global Health
title_full_unstemmed Engineering Approaches in Plant Molecular Farming for Global Health
title_sort engineering approaches in plant molecular farming for global health
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/34db2a8db141455c95644fe640a01266
work_keys_str_mv AT advaitaacaryasingh engineeringapproachesinplantmolecularfarmingforglobalhealth
AT priyenpillay engineeringapproachesinplantmolecularfarmingforglobalhealth
AT tsepolebiletsatsekoa engineeringapproachesinplantmolecularfarmingforglobalhealth
_version_ 1718410207131860992